Total Valuation
Xtl Bio has a market cap or net worth of ₪18.92M. The enterprise value is 5.24M.
Market Cap₪18.92M
Enterprise Value5.24M
Share Statistics
Xtl Bio has 946,243,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding946,243,350
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Xtl Bio’s return on equity (ROE) is 27.44 and return on invested capital (ROIC) is -11253.33%.
Return on Equity (ROE)27.44
Return on Assets (ROA)-41.98
Return on Invested Capital (ROIC)-11253.33%
Return on Capital Employed (ROCE)6.65
Revenue Per Employee0.00
Profits Per Employee-696.90K
Employee Count10
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Xtl Bio is ―. Xtl Bio’s PEG ratio is -0.00217.
PE Ratio―
PS Ratio0.00
PB Ratio-26.57
Price to Fair Value-26.57
Price to FCF-6.59
Price to Operating Cash Flow-5.73
PEG Ratio-0.00217
Income Statement
In the last 12 months, Xtl Bio had revenue of 0.00 and earned -6.97M in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit0.00
Operating Income-1.69M
Pretax Income-759.00K
Net Income-6.97M
EBITDA-1.27M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Xtl Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change-67.21%
50-Day Moving Average1.87
200-Day Moving Average2.65
Relative Strength Index (RSI)56.22
Average Volume (3m)3.17M
Important Dates
Xtl Bio upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Xtl Bio as a current ratio of 0.40, with Debt / Equity ratio of -105.91%
Current Ratio0.40
Quick Ratio0.40
Debt to Market Cap0.04
Net Debt to EBITDA-0.15
Interest Coverage Ratio-241.14
Taxes
In the past 12 months, Xtl Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Xtl Bio EV to EBITDA ratio is -5.48, with an EV/FCF ratio of -6.77.
EV to Sales0.00
EV to EBITDA-5.48
EV to Free Cash Flow-6.77
EV to Operating Cash Flow-6.77
Balance Sheet
Xtl Bio has ₪1.14M in cash and marketable securities with ₪138.00K in debt, giving a net cash position of ₪1.00M billion.
Cash & Marketable Securities₪1.14M
Total Debt₪138.00K
Net Cash₪1.00M
Net Cash Per Share<₪0.01
Tangible Book Value Per Share>-₪0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Xtl Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―